Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
For patients with type 2 diabetes or obesity, tirzepatide represents a well-studied, FDA-approved medication with demonstrated efficacy in clinical trials
How long does the glow last
We seamlessly integrate non-surgical aesthetic solutions into your plan: Results vary by individual, but published clinical trials show average weight loss of 15 to 22% of body weight over 12 to 18 months with semaglutide or tirzepatide when paired with lifestyle changes
Weight loss may plateau, blood glucose targets remain out of reach, or side effects limit long-term use
Results were mixed: some doses showed modest fat loss signals, but trials were short, had small sample sizes, and the compound did not advance to Phase 3
US$ 26.56
US$ 22.28
US$ 20.21
US$ 29.50
US$ 29.26
